These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7692605

  • 1. Recurrent breast cancer: presentation, diagnosis, and treatment.
    Jardines L, Callans LS, Torosian MH.
    Semin Oncol; 1993 Oct; 20(5):538-47. PubMed ID: 7692605
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.
    Metz JM, Schultz DJ, Fox K, Glick J, Solin LJ.
    Cancer J Sci Am; 1999 Oct; 5(2):77-83. PubMed ID: 10198729
    [Abstract] [Full Text] [Related]

  • 3. [Use of adriamycin in the treatment of metastatic breast cancer].
    Dymarskiĭ LIu, Sanchakova AV, Aleksandrova GI, Trishkina EA.
    Vopr Onkol; 1984 Oct; 30(6):67-73. PubMed ID: 6547554
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C, Huang CS, Chao TY, Lu YS, Bu CF, Chen MM, Chang KJ, Cheng AL.
    Cancer; 2002 Nov 15; 95(10):2044-50. PubMed ID: 12412156
    [Abstract] [Full Text] [Related]

  • 5. [4-component chemotherapy and radiation therapy of breast cancer].
    Gritsaĭ AA, Lichinitser MR, Vyshinskaia GV, Kondrat'eva AP, Aplevich NN.
    Ter Arkh; 1986 Nov 15; 58(9):105-8. PubMed ID: 3787480
    [Abstract] [Full Text] [Related]

  • 6. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N.
    J Clin Oncol; 2004 Nov 01; 22(21):4247-54. PubMed ID: 15452182
    [Abstract] [Full Text] [Related]

  • 7. [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
    Rühl U.
    Strahlenther Onkol; 2000 Apr 01; 176(4):196-7. PubMed ID: 10812394
    [No Abstract] [Full Text] [Related]

  • 8. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V, Qutob O, Fox JN, Long ED, Chaturvedi A, Turnbull LW, Drew PJ.
    Eur J Surg Oncol; 2007 Mar 01; 33(2):157-61. PubMed ID: 17085007
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M.
    Ann Surg; 2002 Sep 01; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [Abstract] [Full Text] [Related]

  • 10. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
    Zhou JC.
    Zhonghua Zhong Liu Za Zhi; 1993 May 01; 15(3):215-7. PubMed ID: 8261870
    [Abstract] [Full Text] [Related]

  • 11. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S, Schwartz GF, Komarnicky L, Garcia-Young JA.
    Breast J; 2006 May 01; 12(2):159-64. PubMed ID: 16509842
    [Abstract] [Full Text] [Related]

  • 12. [A case of far advanced breast cancer with distant metastases which had mostly disappeared after chemoendocrine therapy].
    Nishimura H, Takasuna K, Kondo R, Hayashi K, Munakata Y, Kasuga Y.
    Gan To Kagaku Ryoho; 2000 May 01; 27(5):753-7. PubMed ID: 10832447
    [Abstract] [Full Text] [Related]

  • 13. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J, Anglo-Celtic Cooperative Oncology Group.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1076-83. PubMed ID: 15265969
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R, Osaki A, Tanabe K, Toge T.
    Oncol Rep; 2004 Jun 21; 11(6):1265-72. PubMed ID: 15138565
    [Abstract] [Full Text] [Related]

  • 15. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L, Cancer and Leukemia Group B.
    J Clin Oncol; 2003 May 01; 21(9):1825-35. PubMed ID: 12721260
    [Abstract] [Full Text] [Related]

  • 16. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
    Blumenschein GR, DiStefano A, Caderao J, Fristenberg B, Adams J, Schweichler LH, Drinkard L.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 2):2633-7. PubMed ID: 10068266
    [Abstract] [Full Text] [Related]

  • 17. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.
    J Natl Cancer Inst; 2005 Jan 19; 97(2):116-26. PubMed ID: 15657341
    [Abstract] [Full Text] [Related]

  • 18. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
    Kopp R, Classen S, Wolf H, Gholam P, Possinger K, Wilmanns W.
    Anticancer Res; 2001 Jan 19; 21(4B):2995-3000. PubMed ID: 11712800
    [Abstract] [Full Text] [Related]

  • 19. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    Danish Breast Cancer Cooperative GroupDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark. hmn@oncology.dk, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J.
    J Clin Oncol; 2006 May 20; 24(15):2268-75. PubMed ID: 16618947
    [Abstract] [Full Text] [Related]

  • 20. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination].
    Uno H, Fujita M, Hino N, Nakagawa H, Miyagawa H, Aoki J, Taniyama K, Sasaki N.
    Rinsho Ketsueki; 1999 Jul 20; 40(7):556-62. PubMed ID: 10483138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.